A recent article in the BMJ highlighted concerns about the statin Crestor which in 2014 was the most prescribed brand name drug in the US, with 22.3 million prescriptions at a cost of $5.8bn. World-wide sales for 2013 were $8.2bn (1). The report is by Sidney Wolfe, who founded Public Citizen based in Washington DC …
One of the commonly used statins is rosuvastatin, which has the brand name Crestor and is produced by AstraXeneca. It was evaluated in the trial known as JUPITER, which has been subject to considerable criticism (1). In a review of several key aspects, Michel de Lorgeril and colleagues concluded that the results of the trial …
Good Morning Julian, I have just posted this article on my blog at https://vernerwheelock.com/?p=569 More details of the damaging effects of statins will be found at http://www.spacedoc.com/statin_side_effects My primary concern is the fact that such a large number of perfectly healthy people are suffering serious ill-health even though NICE accepts that it will not improve …
The latest edict from the National Institute for Clinical and Health Excellence (NICE) means that virtually everyone over 50 will be recommended to go on statins. NICE recognises that 77 people will have to be treated with these drugs over a 3-year period for one person to derive any benefit (1). It is crucial to …
The Cochrane Collaboration has established a unique reputation for the publication of reports on a variety of topics in the medical field. This is an area where there are very powerful vested interests and the quality of much of the research is questionable. Therefore the contribution of the Collaboration has proved to be extremely valuable …
109. Cochrane Collaboration Evaluates Statins for Primary Prevention of Heart Disease Read More »
Recently I have devoted several posts to the topic of statins (1,2,3). It is obvious that there are many serious doubts about the official/conventional approach to the use of these drugs which have been highlighted by the recent controversy in the BMJ. The results of the special inquiry established by Fiona Godlee, the editor-in-chief of …
105. Statin critics cleared. Top statin advocate knuckles’ rapped Read More »
This is a guest post of an article by Francois Lubbe, editor for The HealthierLife, which originally appeared at: https://www.facebook.com/TheHealthierLife I am very grateful to Francois for permission to publish here. Recently, Dr. John Briffa, contributing editor for The Cholesterol Truth blog,(1) wrote an article about how pro-statin doctors have gone on the offensive against …
So NICE has decided to go ahead with its proposal to recommend that those with a 10% risk of developing heart disease should be considered for treatment with statins. In an article in the BMJ, Professor Mark Baker, the director of the Centre for Clinical Practice at the NICE, stated that 77 people would need …
NICE has just announced that the proposal for all those with a 10% risk of developing heart disease should be offered statins has been confirmed. Effectively this means virtually everyone because even with the healthiest, fittest person there must be at least a 10% chance heart disease will cause their death. Perhaps “the great and …
This is a repost with permission which has been written by Dr John Mandrola. I am very grateful to him for his agreement to publish here. He can be contacted via his web site which is at http://www.drjohnm.org/ Introduction My mind is changing about statins. I’m growing increasingly worried about the irrational exuberance over these …
94. Growing doubt on statin drugs — the problem of drug-lifestyle interaction Read More »